These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7578708)

  • 1. [Prolonged action neuroleptics and the relationship between physician, patient and family].
    Boudef M
    Sante Ment Que; 1995; 20(1):233-47. PubMed ID: 7578708
    [No Abstract]   [Full Text] [Related]  

  • 2. [To increase compliance-knowledge. Only every second schizophrenia patient remains faithful to the therapy].
    MMW Fortschr Med; 2003 May; 145 Suppl 2():108. PubMed ID: 14579500
    [No Abstract]   [Full Text] [Related]  

  • 3. [5 years' experience with prolonged-action neuroleptics].
    Lopez-Ibor Aliño JM; Tabares Pujante J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1973; 1(5):721-31. PubMed ID: 4150175
    [No Abstract]   [Full Text] [Related]  

  • 4. [Schizophrenia: prophylaxis prevents recurrence. Low dose depot neuroleptics--an exit from the "revolving door" psychiatry].
    Fortschr Med Suppl; 1993; 147():1-15. PubMed ID: 9260317
    [No Abstract]   [Full Text] [Related]  

  • 5. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-acting neuroleptics and therapeutic relationship.
    Pelc I
    Acta Psychiatr Belg; 1981; 81(2):154-60. PubMed ID: 6117185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compliance and the rehabilitation alliance.
    Aquila R; Weiden PJ; Emanuel M
    J Clin Psychiatry; 1999; 60 Suppl 19():23-7; discussion 28-9. PubMed ID: 10507277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current questions on the use of neuroleptics in everyday practice].
    Perényi A; Frecska E
    Orv Hetil; 1984 Dec; 125(49):2985-8, 2991. PubMed ID: 6151164
    [No Abstract]   [Full Text] [Related]  

  • 9. Relapse prevention and recovery in the treatment of schizophrenia.
    Schooler NR
    J Clin Psychiatry; 2006; 67 Suppl 5():19-23. PubMed ID: 16822093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depot neuroleptic therapy: clinical considerations.
    Remington GJ; Adams ME
    Can J Psychiatry; 1995 Apr; 40(3 Suppl 1):S5-11. PubMed ID: 7627927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psychological aspects of depot treatment of schizophrenic syndromes].
    Jacobsson L; Odling H
    Lakartidningen; 1980 Oct; 77(40):3522-6. PubMed ID: 6109045
    [No Abstract]   [Full Text] [Related]  

  • 12. The relationship between patient satisfaction and treatment outcomes in schizophrenia.
    Chue P
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):38-56. PubMed ID: 17046986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term treatment of outpatients with depot neuroleptics (author's transl)].
    Saameli W
    Schweiz Rundsch Med Prax; 1981 Feb; 70(6):206-10. PubMed ID: 6113584
    [No Abstract]   [Full Text] [Related]  

  • 14. Atypical antipsychotics in the treatment of schizophrenia. "Informed relationship between doctor and patient" does not exist in many parts of the world.
    Lee S
    BMJ; 2001 Apr; 322(7291):925-6; author reply 927-8. PubMed ID: 11302915
    [No Abstract]   [Full Text] [Related]  

  • 15. Race, family interactions, and patient stabilization in schizophrenia.
    Rosenfarb IS; Bellack AS; Aziz N; Kratz KM; Sayers S
    J Abnorm Psychol; 2004 Feb; 113(1):109-15. PubMed ID: 14992663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raising the bar for treatment expectations in schizophrenia: achieving remission as a routine goal of antipsychotic pharmacotherapy.
    Nasrallah HA; Dursun SM
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):3-5. PubMed ID: 17046983
    [No Abstract]   [Full Text] [Related]  

  • 17. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Position of the pharmacologist. From neuroleptics to non-neuroleptic antipsychotics].
    Costentin J
    Encephale; 2009 Jan; Suppl 3():S119-22. PubMed ID: 19268181
    [No Abstract]   [Full Text] [Related]  

  • 18. Gratification.
    Friedman JH
    Med Health R I; 2003 Dec; 86(12):374. PubMed ID: 14983534
    [No Abstract]   [Full Text] [Related]  

  • 19. [The freedom to suffer from a psychosis--a mother's story].
    Psychiatr Prax; 2003 Apr; 30(3):159-64. PubMed ID: 12692743
    [No Abstract]   [Full Text] [Related]  

  • 20. Psycho-social aspects of treatment with long-acting neuroleptics in Spain.
    Conde-Lopez VJ
    Acta Psychiatr Belg; 1981; 81(2):133-53. PubMed ID: 6117184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.